Relationship between drug treatment services, retention, and outcomes.
about
Factors associated with methadone treatment duration: a Cox regression analysisCross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome ProjectFactors predicting drop out from, and retention in, specialist drug treatment services: a case control study in the North West of EnglandPatient satisfaction and sustained outcomes of drug abuse treatment.Participation in a novel treatment component during residential substance use treatment is associated with improved outcome: a pilot studyCorrelates of substance abuse treatment completion among disadvantaged communities in Cape Town, South AfricaDo drug treatment services predict reunification outcomes of mothers and their children in child welfare?Medical marijuana users in substance abuse treatment.Predictors of longitudinal substance use and mental health outcomes for patients in two integrated service delivery systems.Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.Perceived neighborhood safety, recovery capital, and successful outcomes among mothers 10 years after substance abuse treatmentOrganizational determinants of outpatient substance abuse treatment duration in womenAre There Gender Differences in Arrest Trajectories among Adult Drug Abuse Treatment Participants?Experiences from a community based substance use treatment centre in an urban resettlement colony in India.Individual Patient and Program Factors Related to Prison and Community Treatment Completion in Prison-Initiated Methadone Maintenance Treatment.Police bribery and access to methadone maintenance therapy within the context of drug policy reform in Tijuana, Mexico.Hepatitis infection in the treatment of opioid dependence and abuse.Patient-centered feedback on the results of personality testing increases early engagement in residential substance use disorder treatment: a pilot randomized controlled trial.Drug treatment service utilization and outcomes for Hispanic and white methamphetamine abusers.Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programsEffects of sex composition on group processes in alcohol prevention groups for teens.Treating depression and substance use: a randomized controlled trialPathways to care: narratives of American Indian adolescents entering substance abuse treatment.Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization.Cannabis use by children and young people.Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxificationDevelopment and psychometric validation of a novel patient survey to assess perceived quality of substance abuse treatment in South Africa.Patient experiences questionnaire for interdisciplinary treatment for substance dependence (PEQ-ITSD): reliability and validity following a national survey in NorwayHeterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment.Substance use disorder treatment retention and completion: a prospective study of horse-assisted therapy (HAT) for young adults.Evaluating a bilingual voluntary community-based healthcare organizationThe influence of family and social problems on treatment outcomes of persons with co-occurring substance use disorders and PTSD.The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling.Substance Abuse, Relapse, and Treatment Program Evaluation in Malaysia: Perspective of Rehab Patients and Staff Using the Mixed Method ApproachExplaining long-term outcomes among drug dependent mothers treated in women-only versus mixed-gender programs.NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America.The Impact of Acculturation, Motivation and the Therapeutic Alliance on Treatment Retention and Outcomes for Hispanic Drug Involved Probationers.What could the program have done differently? A qualitative examination of reasons for leaving outpatient treatment.The Washington circle engagement performance measures' association with adolescent treatment outcomes.
P2860
Q28546351-856A9976-86EC-481B-8B66-7793D414F030Q31151002-DE69FB80-9222-4BE7-BBB3-F20A00E015CDQ33332046-B26C8E6F-E55D-494E-AB29-D3125CBB00DEQ33551288-431CB753-B637-4E97-AB5B-072C1D44C8B5Q33719740-A9F1330A-99D3-473E-8166-9AC1E92FE969Q33741714-FC20B2EC-FCD3-486C-9D43-0633CB4AD500Q33765343-9AA51F95-357F-447B-988C-6B543CB9FDBCQ33765980-BB987635-BCF0-4291-B066-88B3BEA9BEC1Q33912719-0E5D4D11-D264-4DC1-AE54-55262A11E7C7Q33972137-38E7C5D4-9737-4447-B332-7AE076DC1559Q33976597-4E64693C-9C74-4185-A136-6F2119BA1F53Q34109848-923FBA1B-7022-4462-8EA5-0E08A9FED4DAQ34255859-D84BCFA0-186F-4D95-A3BD-BE491E1AE333Q34561919-9105E099-7C8A-48C6-891B-DDDD4292D6D9Q34870554-C02A0837-7C70-4579-A442-C333E5498035Q35088335-8854EF0D-67D1-4527-85FF-6F17B801C4E5Q35389163-EC1A8E1A-32E1-4F80-84E1-31DAE5673833Q35575106-8CC26CBB-EC13-493E-8DBC-498DA9955397Q35633843-04753DB9-1C16-4A94-8F7B-49F913832668Q35683154-48186E47-F580-4681-9EAC-C6DC40B7BC99Q35825047-C63A11EC-B4D0-405F-8439-58BC57BC857CQ35916684-1AF6330E-6FE3-454D-866F-4CFF19888745Q35936970-283D83B0-8F58-431A-A242-DA47E5C331EAQ35946549-4FDE1213-77E7-4E72-B8C1-17F537E5DBB4Q36080932-DAEAF257-F7FC-4473-88F2-F11B7626E8F6Q36153554-B6773B2C-E55A-4ABE-89DE-125810DD8B55Q36172571-13CED21C-CC81-47EE-893E-7CB63D5D41CFQ36259249-26D38B73-0375-41ED-A571-2681F3DB6826Q36285635-43A4BD5B-0CD7-4035-9F9D-CE37CACFEEF9Q36322481-1504FBD9-EDDF-444F-A962-782E8A5E4D85Q36354105-5998D17E-F6A5-4C31-B651-058C74F30691Q36891584-5B5A75A5-F678-48D6-A24F-C9DE832A1839Q36892549-3E6CBB10-4CDE-4A0C-8649-5758E44FB14BQ36920520-54967C3D-6885-48FC-83DF-2BCCEECBC9A2Q36939428-78059672-B1CA-423D-9145-38932802B8FEQ37051666-C37A7DFC-DDAA-4B24-8A47-A20EFDE8ACB0Q37091192-0A75CF57-28E9-4AC4-9136-85DED330EC9FQ37104323-AE727C21-EF27-4953-BBAC-3F51730FF519Q37276888-CB52A2D6-6184-49BA-ABA5-1130185E3676Q37277610-D9D7C461-ECA7-4827-B7BD-967BBA58A91A
P2860
Relationship between drug treatment services, retention, and outcomes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Relationship between drug treatment services, retention, and outcomes.
@en
Relationship between drug treatment services, retention, and outcomes.
@nl
type
label
Relationship between drug treatment services, retention, and outcomes.
@en
Relationship between drug treatment services, retention, and outcomes.
@nl
prefLabel
Relationship between drug treatment services, retention, and outcomes.
@en
Relationship between drug treatment services, retention, and outcomes.
@nl
P2093
P356
P1433
P1476
Relationship between drug treatment services, retention, and outcomes.
@en
P2093
David Huang
Douglas M Anglin
Elizabeth Evans
Yih-Ing Hser
P304
P356
10.1176/APPI.PS.55.7.767
P577
2004-07-01T00:00:00Z